engleski

UPPER EXTREMITY DEEP VENOUS THROMBOSIS IN ONCOLOGICAL PATIENTS - CASE REPORT

Upper extremity deep venous thrombosis (UEDVT) makes approximately 4% to 20% of all venous thromboembolism (VTE). Cancer is the most relevant acquired thrombotic risk factor of VTE, because of its myriad of prothrombotic molecules released by neoplastic cells. In our case report we presented deep venous thrombosis (CVT) of the upper limb that is not associated with central venous catheter (CVC) or receiving chemotherapy or hormaonal therapy. A 55-ywar old female patient was admitted to our Department of Transfusion Medicine because of the swelling and pain in the left arm. One month earlier she underwent left segmentectomy and axillary dissection beacuse of the breast cancer. Physical examination revealed left arm swelling and pressure pain. D-dimers were 770ug/L. Duplex ultrasound revealed thrombogenic mass in the left brachial vein, without total obstruction. She was treated with low molecular mass heparin (LMWH) and warfarin. This uncommon presentation of hypercoagulabile state in cancer patient points out one more time the importance of prophylactic use of anticoagulants in any hospitalized cancer patients undergoing surgery. We use low doses of LMWH eight hours after surgery and once daily until discharge.

deep venous thrombosis ; LMWH ; warfarin ; d-dimers

nije evidentirano